Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbbott Laboratories Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 14 | $1.05 | $1.08 | $1.07 |
| Q2 2025 | 14 | $1.25 | $1.29 | $1.26 |
| Q3 2025 | 16 | $1.29 | $1.33 | $1.30 |
| Q4 2025 | 16 | $1.49 | $1.51 | $1.50 |
| Q1 2026 | 13 | $1.15 | $1.22 | $1.20 |
| Q2 2026 | 5 | $1.36 | $1.41 | $1.38 |
| Q3 2026 | 5 | $1.43 | $1.49 | $1.45 |
| Q4 2026 | 5 | $1.60 | $1.66 | $1.63 |
| Q1 2027 | 5 | $1.31 | $1.36 | $1.33 |
| Q2 2027 | 5 | $1.50 | $1.56 | $1.53 |
| Q3 2027 | 5 | $1.58 | $1.65 | $1.61 |
| Q4 2027 | 5 | $1.72 | $1.79 | $1.75 |
Abbott Laboratories Earnings Date And Information
Abbott Laboratories last posted its earnings results on Wednesday, October 15th, 2025. The company reported $1.3 earnings per share for the quarter, missing analysts' consensus estimates of $1.3 by $0. The company had revenue of 11.37 B for the quarter and had revenue of 41.95 B for the year. Abbott Laboratories has generated $8 earnings per share over the last year ($7.64 diluted earnings per share) and currently has a price-to-earnings ratio of 15.28. Abbott Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 15th, 2025 based on prior year's report dates.
Abbott Laboratories Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2025 | Q3 2025 | N/A | $0.94 | N/A | $11.39 B | $11.37 B |
| 07/30/2025 | Q2 2025 | N/A | $1.02 | N/A | $11.09 B | $11.14 B |
| 04/30/2025 | Q1 2025 | N/A | $0.76 | N/A | N/A | $10.36 B |
| 02/21/2025 | Q4 2024 | N/A | $5.33 | N/A | N/A | $10.97 B |
| 10/31/2024 | Q3 2024 | N/A | $0.95 | N/A | $10.55 B | $10.64 B |
| 07/31/2024 | Q2 2024 | N/A | $0.75 | N/A | $10.37 B | $10.38 B |
| 05/02/2024 | Q1 2024 | N/A | $0.71 | N/A | N/A | $9.96 B |
| 02/16/2024 | Q4 2023 | N/A | $0.92 | N/A | N/A | $10.24 B |
| 11/01/2023 | Q3 2023 | N/A | $0.83 | N/A | $9.84 B | $10.14 B |
| 08/03/2023 | Q2 2023 | N/A | $0.79 | N/A | $9.71 B | $9.98 B |
| 05/04/2023 | Q1 2023 | N/A | $0.76 | N/A | $9.67 B | $9.75 B |
| 02/17/2023 | Q4 2022 | N/A | $0.59 | N/A | $9.66 B | $10.09 B |
| 11/01/2022 | Q3 2022 | N/A | $0.82 | N/A | $9.65 B | $10.41 B |
| 08/02/2022 | Q2 2022 | N/A | $1.15 | N/A | $10.33 B | $11.26 B |
| 05/03/2022 | Q1 2022 | N/A | $1.40 | N/A | $11.00 B | $11.90 B |
| 02/18/2022 | Q4 2021 | N/A | $1.13 | N/A | $10.71 B | $11.47 B |
| 11/03/2021 | Q3 2021 | N/A | $1.19 | N/A | $9.56 B | $10.93 B |
| 08/04/2021 | Q2 2021 | N/A | $0.67 | N/A | $9.69 B | $10.22 B |
| 05/05/2021 | Q1 2021 | N/A | $1.01 | N/A | $10.69 B | $10.46 B |
| 02/19/2021 | Q4 2020 | N/A | $1.22 | N/A | $9.94 B | $10.70 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Abbott Laboratories Earnings: FAQ's
Abbott Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 15th, 2025 based offlast year's report dates.
The conference call for Abbott Laboratories's latest earnings report can be listened to online.
The conference call transcript for Abbott Laboratories's latest earnings report can be read online.
Abbott Laboratories (:ABT) has a recorded annual revenue of $41.95 B.
Abbott Laboratories (:ABT) has a recorded net income of $13.40 B.Abbott Laboratories has generated $7.67 earnings per share over the last four quarters.
Abbott Laboratories (:ABT) has a price-to-earnings ratio of 15.28 and price/earnings-to-growth ratio is -123.14.